Transomic Technologies

Better Functional Genomics

BioCat's partner Transomic Technologies was founded in 2011 for the purpose of supplying life science researchers with next-generation gene modulation tools derived from the latest advancements in biotechnology to help unravel genetic complexity and understand disease development. Today, Transomic has an extensive inventory of CRISPR-Cas9 reagents for gene editing, RNAi tools for gene knockdown and a comprehensive offering of gene overexpression systems. Their focus is to deliver technologies enabling discovery across the genome.

Transomic's high-qulity tools for genen function analysis, their knowledge and process-proven platforms combined with BioCat’s outstanding customer service makes us a top genomic solutions provider.